Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NAMPT | P43490 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3882866 | 0.90 | RAB9A (0.62) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3874296 | 0.87 | SMN1; SMN2 (0.62) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3873710 | 0.85 | PKM (0.61) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3873358 | 0.84 | CYP19A1 (0.61) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3877687 | 0.81 | ALDH1A1 (0.54) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL22387485 | 0.81 | ALDH1A1 (0.60) | RAB9AALDH1A1SMN1; SMN2LMNAGAA | |
| SCHEMBL3873492 | 0.80 | RAB9A (0.76) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3873960 | 0.79 | PKM (0.74) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3882729 | 0.79 | NSD2 (0.53) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3874054 | 0.78 | RAB9A (0.62) | RAB9APKMHSD11B1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1814846-B1 | 11BETA-HSD1 INHIBITORS | EVOTEC AG (DE) | 2009-04-08 | — | — | EP | disclosed |
| US-20090069323-A1 | 11beta-hsdi inhibitors | EVOTEC AG (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069323-A1 | 11beta-hsdi inhibitors | HSD3B1, HSD3B2, HSD11B1 | RAB9A 4300/4885PKM 1568/4885HSD11B1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.